share_log

NEXGEL to Present at the LD Micro Invitational XII on June 8, 2022

NEXGEL to Present at the LD Micro Invitational XII on June 8, 2022

NEXGEL將於2022年6月8日在第12屆LD Micro邀請賽上亮相
newsfile ·  2022/06/01 07:35

Langhorne, Pennsylvania--(Newsfile Corp. - June 1, 2022) - NEXGEL, Inc. (NASDAQ: NXGL) (NASDAQ: NXGLW) ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will present at the LD Micro Invitational XII being held on June 7 - 9at the Four Seasons Westlake Village in Westlake Village, CA.

賓夕法尼亞州朗霍恩-(新聞文件公司-2022年6月1日)-NEXGL,Inc.(納斯達克:NXGL)(納斯達克:NXGLW)一家領先的醫療保健和消費應用超温和、高水含量水凝膠產品的供應商,宣佈首席執行官Adam Levy將出席6月7日至9日舉行的第12屆LD Micro邀請賽位於加利福尼亞州西湖村的四季西湖村。

Mr. Levy is scheduled to present on Wednesday, June 8, at 10:30AM Pacific Daylight Time and will hold one-on-one meetings with investors throughout the conference. If you would like to book 1x1 investor meetings with NEXGEL, please contact your LD Micro representative or send an email to NEXGEL@kcsa.com.

利維先生定於6月8日(星期三)太平洋夏令時上午10:30發表演講,並將在整個會議期間與投資者進行一對一的會談。如果您想預訂與NEXGEL的1x1投資者會議,請聯繫您的LD Micro代表或發送電子郵件至NEXGEL@kcsa.com。

NEXGEL LD Micro Invitational XII Presentation:
Date: Wednesday, June 8, 2022
Time: 10:30AM - 10:55AM Pacific Daylight Time
Webcast Registration: HERE

NEXGEL LD Micro邀請賽XII演講:
日期:2022年6月8日(星期三)
時間:太平洋夏令時上午10:30-10:55
網絡直播報名:點擊此處

About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

NEXGEL公司簡介
NEXGEL是用於醫療保健和消費應用的超温和、高水含量水凝膠的領先供應商。該公司總部設在賓夕法尼亞州朗霍恩,開發和製造電子束、交聯型水凝膠已有二十多年的歷史。與其戰略合作伙伴一起,NEXGEL已經配製了200多種不同的組合,將天然成分引入温和的皮膚貼片,可以長時間佩戴,幾乎沒有刺激性。

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
valter@kcsa.com

投資者聯繫方式:
董事管理總監瓦爾特·平託
KCSA戰略傳播
212.896.1254
郵箱:valter@kcsa.com

Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com

媒體聯繫人:
拉克爾·科納
KCSA戰略傳播
212.896.1204
郵箱:rcona@kcsa.com

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論